📰 Nasdaq Bdtx News
Nasdaq Bdtx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Bdtx. Real-time updates on events, politics, business and more.
April 7, 2024
Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLC Emerging data show non-classical EGFR mutations...
February 28, 2024
Deerfield Management Company L.P. Series C lessened its stake in shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) by 48.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 930,447 shares of the company’s stock after selling 869,553 shares during […]
January 25, 2024
Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends. Insider & Institutional Ownership 80.6% of Beam […]
November 17, 2023
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 3,350,000 shares, an increase of 12.8% from the October 15th total of 2,970,000 shares. Approximately 9.8% of the shares of the company are short sold. […]
October 29, 2023
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 2,970,000 shares, an increase of 24.3% from the September 30th total of 2,390,000 shares. Approximately 8.7% of the shares of the company are short sold. […]
September 30, 2023
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the target of a large increase in short interest in September. As of September 15th, there was short interest totalling 1,420,000 shares, an increase of 24.6% from the August 31st total of 1,140,000 shares. Currently, 4.1% of the company’s stock are short sold. Based on […]
August 13, 2023
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) saw a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 1,040,000 shares, a decline of 67.3% from the July 15th total of 3,180,000 shares. Based on an average trading volume of 4,090,000 shares, the days-to-cover […]
July 18, 2023
Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $11.00 price objective on the stock. Other research analysts have also recently issued research reports about the stock. Wedbush upgraded shares of Black […]
July 18, 2023
Piper Sandler initiated coverage on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report published on Friday, MarketBeat.com reports. The firm issued an overweight rating and a $11.00 target price on the stock. Several other equities analysts also recently issued reports on BDTX. Stifel Nicolaus raised shares of Black Diamond Therapeutics from […]
July 3, 2023
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) major shareholder Growth N. V. Biotech bought 1,000,000 shares of the business’s stock in a transaction that occurred on Friday, June 30th. The shares were bought at an average price of $5.00 per share, with a total value of $5,000,000.00. Following the completion of the purchase, the […]